References
- Mehta VK, Fisher G, Ford JA, et al. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas. J Gastrointest Surg 2001;5:27-35. https://doi.org/10.1016/s1091-255x(01)80010-x
- Stoop TF, Theijse RT, Seelen LWF, et al. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer. Nat Rev Gastroenterol Hepatol 2024;21:101-124. https://doi.org/10.1038/s41575-023-00856-2
- Hajibandeh S, Hajibandeh S, Intrator C, et al. Neoadjuvant chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: meta-analysis and trial sequential analysis of randomized controlled trials. Ann Hepatobiliary Pancreat Surg 2023;27:28-39. https://doi.org/10.14701/ahbps.22-052
- Huan L, Yu F, Cao D, Zhou H, Qin M, Cao Y. Comparison of neoadjuvant treatment and surgery first for resectable or borderline resectable pancreatic carcinoma: a systematic review and network meta-analysis of randomized controlled trials. PLoS One 2024;19:e0295983. https://doi.org/10.1371/journal.pone.0295983
- Kwasniewska D, Fudalej M, Nurzynski P, et al. How a patient with resectable or borderline resectable pancreatic cancer should be treated-a comprehensive review. Cancers (Basel) 2023;15:4275. https://doi.org/10.3390/cancers15174275
- Luukkonen T. Invited Review Article: Bibliometrics and evaluation of research performance. Ann Med 1990;22:145-150. https://doi.org/10.3109/07853899009147259
- Park S, Bekemeier B, Flaxman A, Schultz M. Impact of data visualization on decision-making and its implications for public health practice: a systematic literature review. Inform Health Soc Care 2022;47:175-193. https://doi.org/10.1080/17538157.2021.1982949
- Ahn SK, Hwang JW. Global trends in immunotherapy research on breast cancer over the past 10 years. J Oncol 2020;2020:4708394. https://doi.org/10.1155/2020/4708394
- Kim H, Shin SP, Hwang JW, Lee JW. Outcomes of laparoscopic common bile duct exploration (LCBDE) after failed endoscopic retrograde cholangiopancreatography versus primary LCBDE for managing cholecystocholedocholithiasis. J Int Med Res 2020;48:300060520957560. https://doi.org/10.1177/0300060520957560
- Lee K, Hwang JW, Sohn HJ, Suh S, Kim SW. A systematic review of progress on hepatocellular carcinoma research over the past 30 years: a machine-learning-based bibliometric analysis. Front Oncol 2023;13:1227991. https://doi.org/10.3389/fonc.2023.1227991
- Bockhorn M, Uzunoglu FG, Adham M, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2014;155:977-988. https://doi.org/10.1016/j.surg.2014.02.001
- Park JK, Hwang JW. Research progress and future directions on intraductal papillary mucinous neoplasm: a bibliometric and visualized analysis of over 30 years of research. Medicine (Baltimore) 2023;102:e33568. https://doi.org/10.1097/MD.0000000000033568
- Takahashi S. How to treat borderline resectable pancreatic cancer: current challenges and future directions. Jpn J Clin Oncol 2018;48:205-213. https://doi.org/10.1093/jjco/hyx191
- de Scordilli M, Michelotti A, Zara D, et al. Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: current evidence and new perspectives. Crit Rev Oncol Hematol 2023;186:104013. https://doi.org/10.1016/j.critrevonc.2023.104013